These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3041428

  • 1. The antifibrinolytic activity of sulfamylon solution.
    Aldridge JH, Weisdorf DJ, Kucan JO.
    Plast Reconstr Surg; 1988 Aug; 82(2):281-4. PubMed ID: 3041428
    [Abstract] [Full Text] [Related]

  • 2. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ, Aldridge JH.
    Thromb Haemost; 1988 Jun 16; 59(3):440-4. PubMed ID: 2973151
    [Abstract] [Full Text] [Related]

  • 3. Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns.
    Lee JJ, Marvin JA, Heimbach DM, Grube BJ.
    J Burn Care Rehabil; 1988 Jun 16; 9(6):602-5. PubMed ID: 3065338
    [Abstract] [Full Text] [Related]

  • 4. Topical sulfamylon reduces engraftment of cultured skin substitutes on athymic mice.
    Boyce ST, Supp AP, Swope VB, Warden GD.
    J Burn Care Rehabil; 1999 Jun 16; 20(1 Pt 1):33-6. PubMed ID: 9934634
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mafenide acetate solution dressings: an adjunct in burn wound care.
    Shuck JM, Thorne LW, Cooper CG.
    J Trauma; 1975 Jul 16; 15(7):595-9. PubMed ID: 1097720
    [Abstract] [Full Text] [Related]

  • 11. An in vivo comparison of topical agents on wound repair.
    Bennett LL, Rosenblum RS, Perlov C, Davidson JM, Barton RM, Nanney LB.
    Plast Reconstr Surg; 2001 Sep 01; 108(3):675-87. PubMed ID: 11698839
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The potential benefit of 5% Sulfamylon Solution in the treatment of Acinetobacter baumannii-contaminated traumatic war wounds.
    Kucan JO, Heggers JP.
    J Burns Wounds; 2005 Feb 22; 4():e3. PubMed ID: 16921408
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safeguards in the use of topical mafenide (Sulfamylon) in burned patients.
    Shuck JM, Moncrief JA.
    Am J Surg; 1969 Dec 22; 118(6):864-70. PubMed ID: 4902276
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated wounds with devitalized tissue.
    Mendelson JA.
    Prehosp Disaster Med; 2001 Dec 22; 16(3):172-4. PubMed ID: 11875802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.